Канада - Енглески - Health Canada

bracco imaging canada - gadobenate dimeglumine - solution - 529mg - gadobenate dimeglumine 529mg - other diagnostic agents

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

he clissmann - gadopentetate dimeglumine - oral solution - 9.38 mg/ml

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ascorbic acid,calcium hydrogen phosphate dihydrate,calcium pantothenate,colecalciferol,dolomite,retinol palmitate,zinc amino acid chelate -

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

bracco spa - gadobenate dimeglumine - solution for injection - 529

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

bracco spa - gadobenate dimeglumine - solution for injection - 0.5m

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: water for injections; meglumine - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).